|
1
|
Ferrara JL, Levine JE, Reddy P and Holler
E: Graft-versus-host disease. Lancet. 373:1550–1561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu Y and Waller EK: Dichotomous role of
interferon-gamma in allogeneic bone marrow transplant. Biol Blood
Marrow Transplant. 15:1347–1353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Socie G and Blazar BR: Acute
graft-versus-host disease: From the bench to the bedside. Blood.
114:4327–4336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi T, Zhao D, Lin CL, Zhang C, Chen Y,
Todorov I, LeBon T, Kandeel F, Forman S and Zeng D: Absence of
donor Th17 leads to augmented Th1 differentiation and exacerbated
acute graft-versus-host disease. Blood. 112:2101–2110. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carlson MJ, West ML, Coghill JM,
Panoskaltsis-Mortari A, Blazar BR and Serody JS: In
vitro-differentiated TH17 cells mediate lethal acute
graft-versus-host disease with severe cutaneous and pulmonary
pathologic manifestations. Blood. 113:1365–1374. 2009. View Article : Google Scholar :
|
|
6
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blazar BR, Taylor PA and Vallera DA: CD4+
and CD8+ T cells each can utilize a perforin-dependent pathway to
mediate lethal graft-versus-host disease in major
histocompatibility complex-disparate recipients. Transplantation.
64:571–576. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maeda Y, Levy RB, Reddy P, Liu C,
Clouthier SG, Teshima T and Ferrara JL: Both perforin and Fas
ligand are required for the regulation of alloreactive CD8+ T cells
during acute graft-versus-host disease. Blood. 105:2023–2027. 2005.
View Article : Google Scholar
|
|
9
|
Marks L, Altman NH, Podack ER and Levy RB:
Donor T cells lacking Fas ligand and perforin retain the capacity
to induce severe GvHD in minor histocompatibility antigen
mismatched bone-marrow transplantation recipients. Transplantation.
77:804–812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh
CL, Yeh YC, Chou AH, Chang SR, Hsiao KN and Yu FW: Induction of a
distinct CD8 Tnc17 subset by transforming growth factor-beta and
interleukin-6. J Leukoc Biol. 82:354–360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amir AL, Hagedoorn RS, van Luxemburg-Heijs
SA, Marijt EW, Kruisselbrink AB, Frederik Falkenburg JH and
Heemskerk MH: Identification of a coordinated CD8 and CD4 T cell
response directed against mismatched HLA Class I causing severe
acute graft-versus-host disease. Biol Blood Marrow Transplant.
18:210–219. 2012. View Article : Google Scholar
|
|
12
|
Pan B, Zeng L, Cheng H, Song G, Chen C,
Zhang Y, Li Z and Xu K: Altered balance between Th1 and Th17 cells
in circulation is an indicator for the severity of murine acute
GVHD. Immunol Lett. 142:48–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hamada H, Garcia-Hernandez Mde L, Reome
JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL and
Dutton RW: Tc17, a unique subset of CD8 T cells that can protect
against lethal influenza challenge. J Immunol. 182:3469–3481. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Surh CD and Sprent J: Homeostasis of naive
and memory T cells. Immunity. 29:848–862. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Blazar BR, Murphy WJ and Abedi M: Advances
in graft-versus-host disease biology and therapy. Nat Rev Immunol.
12:443–458. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Teshima T, Ordemann R, Reddy P, Gagin S,
Liu C, Cooke KR and Ferrara JL: Acute graft-versus-host disease
does not require alloantigen expression on host epithelium. Nat
Med. 8:575–581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matte CC, Liu J, Cormier J, Anderson BE,
Athanasiadis I, Jain D, McNiff J and Shlomchik WD: Donor APCs are
required for maximal GVHD but not for GVL. Nat Med. 10:987–992.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chakraverty R, Eom HS, Sachs J, Buchli J,
Cotter P, Hsu R, Zhao G and Sykes M: Host MHC class II+
antigen-presenting cells and CD4 cells are required for
CD8-mediated graft-versus-leukemia responses following delayed
donor leukocyte infusions. Blood. 108:2106–2113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korngold R and Sprent J: Surface markers
of T cells causing lethal graft-vs-host disease to class I vs class
II H-2 differences. J Immunol. 135:3004–3010. 1985.PubMed/NCBI
|
|
20
|
Sprent J, Schaefer M, Lo D and Korngold R:
Properties of purified T cell subsets. II In vivo responses to
class I vs class II H-2 differences. J Exp Med. 163:998–1011. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu CY, Kirman JR, Rotte MJ, Davey DF,
Perfetto SP, Rhee EG, Freidag BL, Hill BJ, Douek DC and Seder RA:
Distinct lineages of T(H)1 cells have differential capacities for
memory cell generation in vivo. Nat Immunol. 3:852–858. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Joe G, Hexner E, Zhu J and
Emerson SG: Host-reactive CD8+ memory stem cells in
graft-versus-host disease. Nat Med. 11:1299–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burrell BE, Csencsits K, Lu G,
Grabauskiene S and Bishop DK: CD8+ Th17 mediate costimulation
blockade-resistant allograft rejection in T-bet-deficient mice. J
Immunol. 181:3906–3914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yen HR, Harris TJ, Wada S, Grosso JF,
Getnet D, Goldberg MV, Liang KL, Bruno TC, Pyle KJ, Chan SL, et al:
Tc17 CD8 T cells: Functional plasticity and subset diversity. J
Immunol. 183:7161–7168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yi T, Chen Y, Wang L, Du G, Huang D, Zhao
D, Johnston H, Young J, Todorov I, Umetsu DT, et al: Reciprocal
differentiation and tissue-specific pathogenesis of Th1, Th2 and
Th17 cells in graft-versus-host disease. Blood. 114:3101–3112.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lai HY, Chou TY, Tzeng CH and Lee OK:
Cytokine profiles in various graft-versus-host disease target
organs following hematopoietic stem cell transplantation. Cell
Transplant. 21:2033–2045. 2012. View Article : Google Scholar : PubMed/NCBI
|
